Skip to main content
. 2015 Mar 16;10(3):e0118887. doi: 10.1371/journal.pone.0118887

Fig 3. HMGB1 has no impact on eosinophil survival ex vivo.

Fig 3

Eosinophils isolated from peripheral blood of normal donors incubated with (A) HMGB1 alone or 10 ng/mL HMGB1 in combination with increasing concentrations of pro-survival cytokines (B) IL-5, (C) IL-13 or (D) GM-CSF for 48 hours and then evaluated with Violet live-dead for the assessment of viability.